BPA Call HT001419A0038-HT001420F0048
Award Date 12/3/19
Potential Completion Date 12/2/20
Potential Value $100K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a defense agency, to TDS Med, Inc., a self-certified small disadvantaged business. The $400,000 contract is for the provision of shortage pharmaceuticals, including blood products, medical inhalations, injectables, and other relevant pharmaceutical products. The contract has a period of performance through September 30, 2016. This award is associated with a larger $2 million...
- This is a firm fixed-price BPA call awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide shortage pharmaceuticals, blood products, oncological products, injectables, orals, and medical inhalations. The $264,000 contract has an ultimate completion date of September 30, 2019. TDS Med, Inc. is an active federal contractor, holding a $2 million Blanket Purchase Agreement with the DHA to provide pharmaceutical products and supplies...
- This is a Firm Fixed Price BPA Call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business. The $300,000 contract is for the supply of shortage pharmaceutical items, including pharmaceuticals, blood products, medical inhalations, and injectables, to support the Bureau of Medicine and Surgery's requirements. This award is a task order issued under a $2 million Blanket Purchase Agreement (BPA) awarded to TDS Med, Inc. by the DHA in...
- The U.S. Defense Health Agency (DHA) awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to TDS Med, Inc., a self-certified small disadvantaged business, to provide shortage pharmaceuticals for the Walter Reed National Military Medical Center (WRNMMC). The contract, valued at $300,000.00, has an ultimate completion date of September 30, 2016. This award is under a larger $2 million BPA with TDS Med, Inc. that was originally awarded by DHA in September 2019 to provide...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Defense's Bureau of Medicine and Surgery to TDS Med, Inc., a self-certified small disadvantaged business, to provide various pharmaceutical products. The $250,000 award has an ultimate completion date of September 30, 2015. TDS Med, Inc. has provided pharmaceutical products and medical supplies in support of COVID-19 response efforts and to address shortages for the Defense Health Agency and...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceutical supplies and drugs for the Walter Reed National Military Medical Center (WRNMMC). The $300,000 contract has an ultimate completion date of September 30, 2015 and was awarded on June 30, 2015. TDS Med, Inc. is an active federal contractor that has previously supported COVID-19 response...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) award to TDS Med, Inc., a small disadvantaged business, by the Defense Health Agency (DHA) for pharmaceutical products. The contract has a ceiling value of $150,000.00 and a period of performance through September 30, 2015. This BPA is part of a larger $2 million IDV (Indefinite Delivery Vehicle) contract awarded to TDS Med, Inc. in September 2019 to provide shortage pharmaceuticals, blood products, medical inhalations, injectables, and...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency within the Department of Veterans Affairs, to TDS Med, Inc., a small disadvantaged business. The contract, valued at $927,340.02, is for the provision of shortage medication to address pharmaceutical supply shortages. TDS Med, Inc. is an experienced federal contractor, holding a $2 million Blanket Purchase Agreement with the Defense Health Agency to provide...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,183.90 contract is to supply the DLA with a variety of pharmaceutical products and medical supplies, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not set-aside and represents an open competition. It is associated with a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,909.60 contract covers the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The award is not set-aside and is part of a...
- HT001419A0038Blanket Purchase Agreement
- HT001419A0038-HT001420F0048BPA Call
The Defense Health Agency awarded a Blanket Purchase Agreement Call contract to TDS Med, Inc. valued at one hundred thousand dollars with a period of performance through December 2nd, 2020. The contract supports the agency's shortage pharmaceutical supplies program and involves the delivery of blood products, relevant pharmaceuticals including orals, injectables, and medical inhalations to address shortages. The firm fixed price contract was awarded on December 3rd, 2019 without a set-aside designation to the Bethesda, Maryland awardee TDS Med, Inc. to fulfill requirements under the agency's pharmaceutical shortage program.
Generated 1/3/24, 8:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($50k) | 9/24/20 | |
| Not listed | Not listed | $150.0k | 12/3/19 |